IDEXX Laboratories Inc (IDXX)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 1,130,058 | 1,113,674 | 1,085,065 | 1,115,687 | 1,097,128 | 1,078,353 | 1,047,898 | 930,820 | 898,765 | 871,429 | 852,563 | 932,750 | 932,028 | 917,932 | 863,826 | 797,821 | 694,524 | 625,060 | 593,006 | 564,033 |
| Revenue (ttm) | US$ in thousands | 3,897,506 | 3,844,819 | 3,784,803 | 3,724,853 | 3,660,953 | 3,587,920 | 3,514,054 | 3,430,970 | 3,367,324 | 3,339,846 | 3,308,606 | 3,274,202 | 3,215,360 | 3,135,208 | 3,046,576 | 2,858,026 | 2,706,655 | 2,591,163 | 2,474,677 | 2,457,188 |
| Operating profit margin | 28.99% | 28.97% | 28.67% | 29.95% | 29.97% | 30.06% | 29.82% | 27.13% | 26.69% | 26.09% | 25.77% | 28.49% | 28.99% | 29.28% | 28.35% | 27.92% | 25.66% | 24.12% | 23.96% | 22.95% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,130,058K ÷ $3,897,506K
= 28.99%
IDEXX Laboratories Inc has shown a relatively stable trend in its operating profit margin over the past few years. The operating profit margin has steadily increased from 22.95% as of March 31, 2020, to a peak of 30.06% as of September 30, 2023. This upward trajectory indicates improving operational efficiency and profitability.
However, there was a slight dip in the operating profit margin in the most recent periods, with a slight decrease from 29.97% as of December 31, 2023, to 28.99% as of December 31, 2024. This reduction may be attributed to various factors such as increased operating costs, changes in pricing strategies, or shifts in sales mix.
Overall, IDEXX Laboratories Inc's operating profit margin has remained relatively healthy and above industry averages, showcasing the company's ability to generate profits from its core operations. Investors and stakeholders may continue to monitor this metric to assess the company's operational efficiency and profitability in the upcoming periods.
Peer comparison
Dec 31, 2024